TipRanks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
Want to see EDIT full AI Analyst Report?

Compare Editas Medicine (EDIT) vs. Competitors

3,586 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Editas Medicine
$3.28
$417.74M
-3.61
-10.00%
4 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.42
$101.52M
-2.30
-51.58%
1 Buy
2 Hold
1 Sell
Hold
Foghorn Therapeutics
$6.69
$249.42M
-4.18
-19.46%
6 Buy
0 Hold
0 Sell
Strong Buy
Elicio Therapeutics
$3.01
$49.02M
-0.89
-83.52%
1 Buy
1 Hold
0 Sell
Moderate Buy
Vor Biopharma
$24.01
$1.30B
-0.07
-29.61%
4 Buy
1 Hold
0 Sell
Strong Buy
Caribou Biosciences
$1.65
$140.44M
-1.20
-26.97%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EDIT
Editas Medicine
2.70
-0.30
-10.00%
CLLS
Cellectis SA
1.53
-2.14
-58.31%
FHTX
Foghorn Therapeutics
4.14
-0.84
-16.87%
ELTX
Elicio Therapeutics
1.89
-9.25
-83.03%
VOR
Vor Biopharma
21.40
-6.54
-23.41%
CRBU
Caribou Biosciences
1.30
-0.63
-32.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts